Moreover, our genomic analysis revealed a correlation between CTSL and mutations in P53, ATRX, and PTEN, and TP53 mutations were associated with poor survival in HNSCC patients and tumor resistance to radiation and chemotherapy clinically (22). The gene discussed is ATRX; the disease is neoplasm.